Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains

For newly diagnosed breast cancer, estrogen receptor status (ERS) is a key molecular marker used for prognosis and treatment decisions. During clinical management, ERS is determined by pathologists from immunohistochemistry (IHC) staining of biopsied tissue for the targeted receptor, which highlight...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Nikhil, Madani, Ali, Esteva, Andre, Keskar, Nitish Shirish, Press, Michael F., Ruderman, Daniel, Agus, David B., Socher, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670411/
https://www.ncbi.nlm.nih.gov/pubmed/33199723
http://dx.doi.org/10.1038/s41467-020-19334-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670411/
https://www.ncbi.nlm.nih.gov/pubmed/33199723
http://dx.doi.org/10.1038/s41467-020-19334-3

Ejemplares similares